Leyva-Jiménez R, Olvera-Torres P, Álvarez-Córdova MM, Alcántar-Saldívar EL

Language: Spanish
References: 24
Page: 473-479
PDF size: 155.05 Kb.

ABSTRACT

Objective: to determine the prevalence of irritable bowel syndrome (IBS) in adults between 20-49 years of age that are attended at a medical offices at UMF 53 of the IMSS, León, Guanajuato.
Material and methods: all adult patients between 20-49 years old that attended medical offices at UMF 53 were carried out a survey to diagnose SII according to the approaches of Rome II.
Results: 246 patients were studied, 85 patients (35 %) had a diagnosis of IBS. Of those 85 patients, 8 patients (9 %) had IBS with prevalence of diarrhea, 41 patients (48 %) to the subgroup of IBS had prevalence of constipation and 32 patients (42 %) with IBS had alternating symptoms; 18 patients (21 %) they were men and 67 patients (79 %) were women.
Conclusions: prevalence of IBS in adults between 20-49 year-old attending to medical offices at UMF 53 of the IMSS, León, Guanajuato, is of 35 %, being more frequent the IBS with constipation.

REFERENCES

1. Sander V. Diagnosing irritable bowel syndrome. Rev Gastroenterol Disord 2003;3(Suppl 2):12-17.

2. Horwitz LB, Lembo JA, Whitehead EW. Tratamiento del síndrome de colon irritable. Atención Medica 2003;16:13-23.

3. Weber HF, Mc Callum WR. Clinical approaches to irritable bowel syndrome. Lancet 1992;340: 1447-1451.

4. Camilleri M. Dyspepsia, irritable bowel syndrome and constipation: review and what’s new. Rev Gastroenterol Disord 2001;1:2-17.

5. Horwitz JB, Fisher SR. The irritable bowel syndrome. N Engl J Med 2001;344:1846-1850.

6. Bonis LP, Northon AR. The challenge of irritable bowel syndrome. Am Fam Physician 1996;53: 1229-1235.

7. Valenzuela J, Alvarado J, Cohen H, Damiao A, Francisconi C, Frugone L, et al. Un consenso latinoamericano sobre el síndrome de intestino irritable. Gastroenterol Hepatol 2004;27:325-343.

8. El-Serag BH. Impact of irritable bowel syndrome: prevalence and effect on health-rekated quality of life. Rev Gastroenterol Disord 2003;3 (Suppl 2):3-11.

9. Talley JN, Spiller R. Irritable bowel syndrome: a little understood organic bowel disease? Lancet 2002;360:555-564.

10. Viera JA, Shaughnessy J. Management of irritable bowel syndrome. Am Fam Physician 2002;66: 1867-1874.

11. Dalton BC, Drossman AD. Diagnosis and treatment of irritable bowel syndrome. Am Fam Physician 1997;55:875-880.

12. American Gastroenterological Association Patient Care Committee. Irritable bowel syndrome: a technical review for practice guideline development. Gastroenterology 1997;2120-2137.

13. Camillen M. Management of the irritable bowel syndrome. Gastroenterology 2001;120:652-668.

14. Locke III GR. Natural history of irritable bowel syndrome and durability of the diagnosis. Rev Gastroenterol Disord 2003;3(Suppl 3):12-17.

15. Balboa A, Martínez G. Breves datos epidemiológicos del síndrome de intestino irritable. Jano 2002;52:800-806.

16. Snape JW. Current concepts in the management of the irritable bowel syndrome. Rev Gastroenterol Mex 1994;59:127-132.

17. Christensen J. Pathophysiology of the irritable bowel syndrome. Lancet 1992;340:1444-1447.

18. Maxwell DM, Mendall MA, Kumor D. Irritable bowel syndrome. Lancet 1997; 350:1691-1695.

19. Talley JN. When to conduct testing in patients with suspected irritable bowel syndrome. Rev Gastroenterol Disord 2003;3(Suppl 3):18-24.

20. American Gastroenterological Association. Medical position statement: irritable bowel syndrome. Gastroenterology 1997;112:2118-2119.

21. Schmulson WM. Síndrome de intestino irritable: otra enfermedad sin base anatómica. Gac Med Mex 2002;138:50-55.

22. Taller NJ. Irritable bowel syndrome. Australian Family Physician 2000;29:823-828.

23. Mínguez-Pérez M, Herreros-Martínez B, Mora-Miguel F, Benages-Martínez A. Síndrome de intestino irritable. Medicine 2004;9:246-252.

24. División Técnica de Información Estadística en Salud. Motivos de consulta en medicina familiar en el IMSS, 1991-2002. Rev Med IMSS 2003;41(5): 441-448.